Author | Sandra Franco, MD

Articles

HER2 Testing and Correlation With Efficacy of Trastuzumab Therapy

October 01, 2002

BySandra Franco, MD|Charles L. Vogel, MD, FACP

The emerging era of targeted cancer therapies has focused laboratory scientists and clinicians on the need to define and understand molecular targets of novel drugs. For breast cancer patients and doctors, this trend is not news-efforts have been under way for decades to identify the estrogen and progesterone receptors and define the value of these markers as predictors of response to hormonal therapy.